Table 3.
Classification | Antimicrobial agent | Total number of administration | Susceptible to the identified microorganism / Cases with no growth of microorganism | |
---|---|---|---|---|
Penams | Penicillin | IV nafcillin | 1 | 0/0 |
Beta lactam/Beta lactamase inhibitor | Oral amoxicillin-clavulanate | 7 | 1 (MSSA) /2 | |
Cephems | 1st generation cephalosporin | IV cefazolin | 5 | 0/3 |
Oral cephalexin | 1 | 0/0 | ||
2nd generation cephalosporin | IV cefotetan | 2 | 0/0 | |
IV cefotiam | 1 | 1 (Streptococcus specis)/0 | ||
3rd generation cephalosporin | IV cefotaxime | 4 | 1 (Pasteurella multocida) /0 | |
IV ceftriaxone | 5 | 1 (Enterobacter cloacae)/0 | ||
Oral cefpodoxime | 4 | 2 (Streptococcus species, Eschericia coli)/1 | ||
Aminoglycoside | IV netilmicin | 1 | 0/0 | |
Lincosamides | Oral clindamycin | 3 | 0/0 | |
Unidentified oral form | 5 | Not available/1 |
IV intravenous, MSSA methicillin-sensitive Staphylococcus aureus